A detailed history of Taylor Financial Group, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Taylor Financial Group, Inc. holds 3,148 shares of LLY stock, worth $2.51 Million. This represents 2.19% of its overall portfolio holdings.

Number of Shares
3,148
Previous 3,199 1.59%
Holding current value
$2.51 Million
Previous $2.49 Billion 14.54%
% of portfolio
2.19%
Previous 1.89%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$724.87 - $909.04 $36,968 - $46,361
-51 Reduced 1.59%
3,148 $2.85 Billion
Q1 2024

May 14, 2024

SELL
$592.2 - $792.28 $592 - $792
-1 Reduced 0.03%
3,199 $2.49 Billion
Q4 2023

Sep 17, 2024

BUY
$525.19 - $619.13 $27,309 - $32,194
52 Added 1.65%
3,200 $1.87 Billion
Q4 2023

Feb 16, 2024

BUY
$525.19 - $619.13 $1.68 Million - $1.98 Million
3,200 New
3,200 $1.87 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $758B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Taylor Financial Group, Inc. Portfolio

Follow Taylor Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Taylor Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Taylor Financial Group, Inc. with notifications on news.